?

Nils-Åke
Hillarp

Karolinska
(Options)


Per
Svenningsson

Pharmacology, KI

Rodrigo A.
Cunha

University of Coimbra

Christer E.
Nordstedt

Eli Lilly & Co

Gunnar
Schulte

Karolinska


Sergi
Ferre

National Institute on Drug Abuse-IRP

Francisco
Ciruela

Universitat de Barcelona


xu
zhang

ION, CAS

Zhi-Qing David
Xu

Capital Medical University, Beijing and Karolinska Institute, Stockholm




Marc
Landry

University of Bordeaux/CNRS


Adelheid
Kresse

Medical University Graz


Long-Chuan
Yu

Peking University

Kjell
Fuxe

Department of Neuroscience,Karolinska Institute,stockholm, sweden



Peter
Lidbrink

Karolinska

Staffan
Andersson

Göteborg University

Kurt
Andersson

Karolinska

Miguel A.
Pérez de la Mora

Biophysics department, instituto de fisiología celular, Biofísica y Neurociencias UNAM

Ledia F
Hernandez

McGovern Instittute for Brain Research, MIT

Maheep
Bhatnagar

Mohan Lal Sukhadia University, Udaipur, India


Sergi
Ferre

National Institute on Drug Abuse-IRP

Daniel
Marcellino

Department of Neuroscience,Karolinska Institute,stockholm, sweden



Gosta
Jonsson

Karolinska



Nils
Lindefors

Karolinska

Kyle J.
Frantz

Georgia State


Sergi
Ferre

National Institute on Drug Abuse-IRP


Friedbert
Weiss

Scripps Institute


Lars
Norlen

Karolinska

Lars
Olson

Karolinska


Ingrid
Stromberg

Umeå University


Jacob
Kjell

Karolinska

Elliot James
Glotfelty

National Institute on Aging/Karolinska Institutet


Jaime M.
Ross

University of Rhode Island


Bengt O. T.
Falck

Lund University

Anders
Björklund

Lund University

Nils-Åke HillarpX